AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: Puma Biotechnology (NERLYNX) (nerlynx.com)
This is a high-substance, low-bullshit site that prioritizes clinical evidence and patient safety over marketing fluff. It is a benchmark for pharmaceutical transparency, where the ‘Signal’ is entirely comprised of ‘Substance.’
Implement JSON-LD Drug and Organization schema to resolve the technical authority gap. Consolidate the multiple ‘You are leaving this website’ H2 tags that clutter the heading hierarchy. Add direct outbound links to ClinicalTrials.gov or PubMed for the cited studies to provide a complete external proof path. Ensure the mentor program’s ‘compensated’ disclaimer is more visually distinct to maintain current high levels of trust.
Information density is exceptionally high. Instead of power words, the site uses specific nouns and technical protocols such as ‘extended adjuvant therapy,’ ‘trastuzumab-based treatment,’ and ‘small molecule targeted therapy.’ Specific metrics are abundant, such as the ‘34% lower risk of recurrence’ in the ExteNET trial and the exact population count of ‘2,840 women.’ The only penalty comes from the necessary but high repetition of diarrhea management instructions across all four pages.
A validator checks markup – an AI system checks whether your structure encodes meaning. Start your free one page HTML interpretation to see what your page looks like inside a real chunker.
There is no detectable semantic drift. The homepage H1 (Reducing Recurrence) is immediately and consistently supported by the sub-pages which detail exactly how the drug reduces recurrence for both early-stage and metastatic patients. The messaging remains clinically focused without shifting into generic ‘wellness’ or ‘lifestyle’ promises that often plague pharmaceutical marketing.
Identify the current state and friction diagnosis of your specific business model. Generate your Executive SEO Strategy to quantify the financial or conversion cost of strategic misalignment.
The site avoids common trust theatre traps like unverified star ratings or fake badges. While it uses patient testimonials (Sherry H, Edwina L), they are strictly regulated with legal disclaimers noting compensation and that experiences vary. The proof_links_count of 3 reflects clinical evidence and patient information links rather than social media fluff.
Proof density is significantly higher than the industry average. Every major efficacy claim is tied to a specific clinical trial (ExteNET or the metastatic phase 3 trial), and the site provides both relative risk reductions (34%) and absolute numbers (94.2% vs 91.9%) to ensure full transparency. There are 10+ instances of specific, verifiable evidence across the analyzed pages.
For a demonstration of entity driven retail architecture, open the Walmart Structured Data audit. View the Walmart Structured Data Audit to see how product, brand, and service entities are reconstructed for AI systems.
The value proposition is drug-specific and cannot be copy-pasted onto a competitor. While it uses industry jargon like ‘clinical trial data’ and ‘mechanism of action,’ these are presented as verifiable technical deliverables. Boilerplate sections are minimal, though the ‘Support for you and your family’ section uses standard industry templates for patient assistance programs.
The primary authority gap is technical; the crawl shows null for schema_json, indicating a lack of structured data to identify the organization or the drug via Schema.org/Drug properties. While the brand authority is clear through its clinical data, the digital footprint lacks the structured verification (sameAs links to regulatory filings) expected of a technical leader.
There is no disconnect between claims and evidence. Performance claims like ‘59% reduction in the risk of central nervous system (CNS) metastases’ are cited as part of a 5-year special analysis of the ExteNET study. The site transparently admits when conclusions cannot be drawn from specific sub-analyses, which is the opposite of bullshit.
Medical Devices, Pharma & Biotech BS: Puma Biotechnology (NERLYNX) (nerlynx.com)
The content perfectly matches the Pharma & Biotech industry category. It focuses exclusively on the therapeutic area of HER2+ breast cancer and provides granular clinical trial data for the drug neratinib.
The access layer decides whether your content even enters the model's world. Review the Crawlability & Indexation Framework to see how AI visible content differs from what humans see in the browser.
“The score of 14 is driven primarily by technical gaps (missing schema) and necessary concept repetition. In all other pillars, the site scores near-zero for BS because it replaces generic marketing claims with forensic clinical data and specific regulatory-approved safety protocols.”
Analysis Disclosure & Source Attribution
Snapshot Date: May 24, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at Puma Biotechnology (NERLYNX) to view the most current version of their content and see directly what the company offers.